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TT virus (TTV) DNA was quantitated in the serum and nine autopsy tissues (bone marrow, lymph node, muscle, thyroid
gland, lung, liver, spleen, pancreas, and kidney) obtained from each of three TTV-infected subjects by real-time polymerase
chain reaction (PCR), which can detect all TTV genotypes. TTV DNA was detected in all examined tissues, with the viral load
being equal to or up to 300 times higher than that in the corresponding serum (2.1 3 105 to 5.3 3 107 copies/g vs 1.2–3.9 3
105 copies/ml). Generally, the TTV viral load was higher in the bone marrow, lung, spleen, and liver than in the other tissues,
although it varied by individual. Restriction fragment length polymorphism (RFLP) analysis of the PCR-amplified TTV DNA of
3.3 kilobases (kb) revealed considerable differences among the TTVs in the serum and tissue specimens from each subject.
Further, the 3.3-kb amplicons from the serum and tissue specimens from one subject were molecularly cloned, and 30 clones
each from the serum and each tissue specimen were subjected to RFLP and sequence analysis (total, 300 clones): the TTV
clones were classified into six genotypes including four novel genotypes. The genotypic variability was remarkable: each
specimen had one to five TTV genotypes at different frequencies. TTV DNA in replicative intermediate forms and TTV mRNA
were detectable in all tissues tested. These results indicate the broad, uneven distribution of TTV genotypes in tissues and
suggest that viral replication takes place in multiple tissues at distinct levels in infected individuals. © 2001 Academic Press
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TT virus (TTV) was first isolated from the serum of a
patient with posttransfusion hepatitis of unknown etiol-
ogy in 1997 (Nishizawa et al., 1997). TTV has been visu-
lized by electron microscopy and was found to be an
nenveloped, small, spherical particle with a diameter of
0–32 nm (Itoh et al., 2000). It has a negative-sense,
ingle-stranded circular DNA genome of approximately
.8 kilobases (kb) (Miyata et al., 1999; Mushahwar et al.,
1999; Okamoto et al., 1998a, 1999b). Due to the differ-
ences in the genomic and physicochemical features be-
tween TTV and members of the Circoviridae family, in-
cluding porcine circovirus, beak and feather disease
virus of parrots, and chicken anemia virus (Todd et al.,
2000), various research groups have proposed that TTV
belongs to a new virus family tentatively designated
Circinoviridae (Mushahwar et al., 1999), Paracircoviridae
(Takahashi et al., 2000b), or the TTV family (Tanaka et al.,
2001). TTV has an extremely wide range of sequence
divergence (Khudyakov et al., 2000; Okamoto et al.,
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3581999c), and the TTV genomes are tentatively classified
into at least 23 genotypes with sequence divergence of
.30% from one another (Muljono et al., 2001), or into four
major phylogenetic groups (Muljono et al., 2001; Tanaka
et al., 2001): eight genotypes of the SEN virus (SENV:
SENV-A to SENV-H) are considered to be members of
one group composed of TTV of genotypes 9–16 and
18–20, represented by SANBAN, TJN01, and TUS01 iso-
lates (Hijikata et al., 1999; Mushahwar, 2000; Okamoto et
al., 1999b; Tanaka et al., 2001; Ukita et al., 2000).
Circular, double-stranded TTV DNA in replicative in-
termediate forms has been detected in the liver and bone
marrow, suggesting that TTV can replicate in these tis-
sues (Okamoto et al., 2000d,e). Three distinct mRNAs of
2.9–3.0, 1.2, and 1.0 kb with common 59 and 39 termini,
which are transcribed from the genomic, minus-strand of
TTV DNA, have recently been observed in culture cells
transfected with recombinant TTV DNA as well as in the
bone marrow cells obtained from an infected human
(Kamahora et al., 2000; Okamoto et al., 2000b). These
three mRNAs have in common a short splicing of approx-
imately 100 nucleotides (nt). The 1.2- and 1.0-kb mRNAs
possess an additional splicing of approximately 1700
and 1900 nt, respectively, leading to the creation of two
novel open reading frames (ORF3 and ORF4).
TTV is blood borne and is shed into feces via secretion
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359TISSUE DISTRIBUTION OF TT VIRUSfrom the liver into the bile (Nishizawa et al., 1997; Oka-
oto et al., 1998b; Ukita et al., 1999), indicating that TTV
ay have characteristics different from other blood-
orne viruses. The infectivity of TTV in feces has recently
een demonstrated in a chimpanzee transmission study
Tawara et al., 2000). Hence, the extensive spread of TTV
n the general population has been caused not only by
arenteral transmission via transfusion of blood or blood
roducts, but also by nonparenteral transmission
hrough fecal–oral infection. In previous reports, TTV
NA has been detected in peripheral blood mononu-
lear cells (PBMC) obtained from infected individuals
Lopez-Alcorocho et al., 2000; Okamoto et al., 1999a;
Okamura et al., 1999), and it was found that the TTV
genotypes in the PBMC and plasma from the same
individuals differed (Okamoto et al., 1999a, 2000c). How-
ever, the precise range of replication sites of TTV and the
distribution of TTV genotypes in tissues of the body are
still unclear.
Therefore, the aim of the present study was to define the
distribution and replication of TTV in various tissues of
infected humans. The viral DNA in the serum and various
autopsy tissues obtained from three TTV-infected subjects
was quantitated by polymerase chain reaction (PCR), and
the tissues were tested for double-stranded TTV DNA and
TTV mRNAs as an indirect assay for viral replication. Fur-
thermore, the genotypes of TTV in the serum and tissue
specimens were determined by PCR with type-specific
primers and sequence analysis to find any differences in
the distribution of TTV genotypes among them.
RESULTS
The titer of TTV DNA in serum and tissue specimens
TABLE 1
Quantitation of TTV DNA in the Sera and Various Autopsy Tissues
from Subjects A, B, and C
Specimen
TTV viral load (copies per ml of serum
or per g of tissue)
Subject A Subject B Subject C
Serum 2.8 3 105 3.9 3 105 1.2 3 105
Bone marrow 2.7 3 107 5.3 3 107 3.6 3 107
Lymph node 1.6 3 106 1.1 3 106 9.1 3 105
Muscle 2.1 3 105 5.6 3 105 5.7 3 105
Thyroid gland 3.8 3 106 4.5 3 105 2.2 3 105
Lung 3.8 3 107 4.7 3 106 NTa
Liver 8.2 3 106 4.2 3 106 2.2 3 106
Spleen 1.5 3 107 4.1 3 106 4.7 3 106
Pancreas 5.3 3 105 1.0 3 107 1.6 3 106
Kidney 8.9 3 105 1.2 3 106 3.0 3 105
a NT, not tested.Table 1 shows the viral load of TTV in the serum and
various autopsy tissues obtained from the three TTV-infected patients. The level of TTV DNA in the circulation
in the three subjects ranged from 1.2 3 105 to 3.9 3 105
copies/ml by real-time untranslated region (UTR) PCR,
which can detect all TTV genotypes. On the other hand,
the titers of TTV DNA in the nine tissues tested ranged
from 2.1 3 105 to 3.8 3 107 copies/g in Subject A, from
4.5 3 105 to 5.3 3 107 copies/g in Subject B, and from
.2 3 105 to 3.6 3 107 copies/g in Subject C, being nearly
qual to or up to 300 times higher than that in the
espective serum. The TTV viral load tended to be higher
n the bone marrow, spleen, lung, and liver, and lower in
he muscle and kidney, although it varied by individual in
strict sense.
etection of double-stranded TTV DNA in tissues
The extracted nucleic acids from the tissue specimens
ith a TTV DNA titer greater than 106 copies/g were
subjected to agarose gel electrophoresis and the strand-
edness of TTV DNA in each gel slice was analyzed.
Double-stranded TTV DNAs representing replicative in-
termediates, which migrated to the area corresponding
to 3.3–6.1 kb and were resistant to treatment with S1
nuclease and sensitive to restriction endonuclease,
were detected not only in the liver and bone marrow in
accordance with previous reports (Okamoto et al.,
2000d,e), but also in six other tissues (lymph node, thy-
roid gland, lung, spleen, pancreas, and kidney) obtained
from one or more of the three studied subjects. Further-
more, after treatment with S1 nuclease, extracted nucleic
acids from the serum and tissue specimens were tested
for TTV DNA by real-time UTR PCR (Table 2). Reflecting
TABLE 2
Quantitation of Double-Stranded TTV DNA in the Sera and Various
Autopsy Tissues from Subjects A, B, and C
Specimen
The titer of double-stranded TTV DNA
(copies per g of tissue)a
Subject A Subject B Subject C
Serum (2)b (2) (2)
Bone marrow 1.3 3 107 (48%)c 2.7 3 107 (51%) 2.1 3 107 (58%)
Lymph node 2.7 3 105 (17%) 1.2 3 105 (11%) 5.3 3 104 (6%)
uscle 4.6 3 104 (22%) 7.2 3 104 (13%) 1.5 3 105 (26%)
Thyroid gland 1.0 3 106 (26%) 8.9 3 104 (20%) 4.4 3 104 (20%)
Lung 1.3 3 107 (34%) 9.8 3 105 (21%) NTd
Liver 2.2 3 106 (27%) 9.6 3 105 (23%) 7.7 3 105 (35%)
Spleen 4.8 3 106 (32%) 6.2 3 105 (15%) 1.6 3 106 (34%)
Pancreas 8.6 3 104 (16%) 1.6 3 106 (16%) 3.5 3 105 (22%)
Kidney 1.5 3 105 (17%) 2.5 3 105 (21%) 3.1 3 104 (10%)
a The titer of double-stranded TTV DNA was determined as de-
cribed under Materials and Methods.
b (2), negative for double-stranded TTV DNA.
c The percentage of double-stranded TTV DNA against the total TTVDNA in that specimen (Table 1) is shown in parentheses.
d NT, not tested.
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360 OKAMOTO ET AL.the single-stranded nature of the genomic DNA in TTV
virions (Okamoto et al., 1998a), TTV DNA was not de-
ected in any of the three serum samples after the treat-
ent with S1 nuclease. In contrast, TTV DNA was de-
ected in all tissue specimens after treatment with S1
uclease, including those with low TTV DNA titer (less
han 106 copies/g) such as the muscle, thyroid gland, and
kidney. When further treated with restriction endonucle-
ases, TTV DNA was not amplifiable, thereby indicating
the double-strandedness of TTV DNA in the S1 nuclease-
treated nucleic acid samples obtained from all tissues.
The double-stranded forms of TTV DNA comprised 48 to
58% of the total in the bone marrow, and 6 to 17% in the
lymph node.
Distribution and relative titer of TTV of genotypes 1
to 4 in serum and tissue specimens
Semiquantitation of the four common TTV genotypes
(1, 2, 3, and 4) was performed by nested PCR with
type-specific primers (Table 3). In the serum samples
from the three patients, either TTV of genotype 1 alone
(Subjects A and C) or TTV genotypes 1 and 2 (Subject B)
were detected, and the titer ranged from 102 to 104
copies/ml. However, several TTV genotypes that were
not detected in the serum sample were detectable in
some of the tissue specimens: genotype 4 TTV was
detected in the lung and spleen of Subject A; genotype 3
TTV was detected in the bone marrow, thyroid gland, and
spleen of Subject B; and genotype 2 TTV was detected in
the pancreas of Subject C. In Subject A, genotype 1 TTV
was detected only in the liver, pancreas, and kidney at a
titer 10- to 100-fold higher than that in the circulation. In
Subject B, TTV of genotypes 1 and 2 were detected in all
tissues tested at a titer comparable with or 10 to 100
T
Quantitation of TTV of Genotypes 1–4 in the Sera
Specimen
TTV viral load (copies p
Subject A
1 2 3 4 1
Serum 102 — — — 103
Bone marrow — — — — 105
Lymph node — — — — 104
Muscle — — — — 103
Thyroid gland — — — — 104
Lung — — — 104 103
Liver 104 — — — 105
Spleen — — — 103 104
Pancreas 103 — — — 104
Kidney 104 — — — 105
a NT, not tested.times higher than that in the serum. In Subject C, TTV of
genotype 1 was detected in all tested tissues at a titer
s
5comparable with or 10-fold higher than that in the serum.
However, the TTV viral load of these four genotypes was
10–107 times lower than that in the corresponding spec-
men detectable by the abovementioned PCR that can
etect essentially all TTV genotypes, suggesting the
resence of TTV genotype(s) other than the four common
enotypes, not only in the serum but also in the tissue
pecimens.
estriction fragment length polymorphism (RFLP)
nalysis of 3.3-kb TTV DNA fragment amplified from
erum and tissue specimens
PCR–RFLP analysis of the 3.3-kb TTV DNA fragment
hat was amplified from each of the serum and tissue
pecimens of the three patients and digested with re-
triction enzyme Sau3AI, DraI, or MvaI showed consid-
rable differences, suggesting the uneven distribution of
istinct TTV strains in the serum and tissues. Figure 1
hows the results of PCR–RFLP of the serum and nine
issue specimens from each subject using the restriction
ndonuclease, MvaI.
olecular cloning and genotyping of 3.3-kb TTV DNA
ragment
To further analyze the heterogeneous nature of the
TV distributed in various tissues of the infected host,
he 3.3-kb PCR-amplified products from the serum and
issue specimens in Subject A were molecularly cloned,
nd 30 clones each were isolated and subjected to RFLP
nalysis. A total of 300 clones were classified into three
ajor groups (consisting of 142 clones, 85 clones, and
3 clones, respectively) and three minor groups (two to
ix clones) based on the RFLP patterns. Twenty clones
rious Autopsy Tissues from Subjects A, B, and C
f serum or per g of tissue) of each genotype
Subject B Subject C
2 3 4 1 2 3 4
04 — — 104 — — —
06 103 — 105 — — —
04 — — 104 — — —
04 — — 104 — — —
04 103 — 104 — — —
05 — — NTa NT NT NT
05 — — 105 — — —
05 104 — 105 — — —
05 — — 104 103 — —
04 — — 104 — — —ABLE 3
and Va
er ml o
1
1
1
1
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1elected from the six groups were sequenced at both the
9 and the 39 ends: the sequence of 471 to 600 nt
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361TISSUE DISTRIBUTION OF TT VIRUS(AB060592–AB060625) at each end of the 20 clones were
compared and subjected to phylogenetic analysis. These
results confirmed the presence of six distinct groups.
One isolate was selected from each of the six groups,
and the entire 3.3-kb sequence of the SAa-01, SAa-10,
SAa-38, SAa-39, SAf-09, and SAj-30 isolates (AB060592–
AB060597) were determined. Pairwise comparison
within the 3.3-kb sequence revealed that they are only
55.7–72.8% similar to each other.
The sequence of open reading frame 1 (ORF1) of the
six TTV clones were compared against that of all known
TTV isolates of genotypes 1–3 and 10–23, whose entire
sequence of ORF1 has been determined. A phylogenetic
tree was constructed by the neighbor-joining method
(Fig. 2). The tree disclosed that two (SAa-39 and SAa-38)
of the six TTV clones were classifiable into genotype 18,
which is represented by the TYM9 isolate (Okamoto et
l., 2000b), and genotype 19, which is represented by the
ENV-F isolate (Tanaka et al., 2001), respectively, but the
emaining four clones could not be classified into the
nown TTV genotypes. Although the entire sequence of
RF1 of the TTV isolates of genotypes 4 to 9 have not
een reported, they had sequence divergence of .30%
with the newly identified four clones based on the partial
sequence of 222–225 nt in the central portion of ORF1.
For the simplicity of nomenclature, the four clones (SAa-
10, SAj-30, SAf-09, and SAa-01) were tentatively desig-
nated as genotypes 24, 25, 26, and 27 in the present
study.
Distribution of the six TTV genotypes in the serum
and tissue specimens of Subject A
FIG. 1. RFLP analysis of the 3.3-kb TTV DNA sequences amplified fro
The 3.3-kb PCR-amplified product was digested with a restriction endon
viral sequence recovered from the serum. The tissues examined includ
(Lg), liver (Lv), spleen (Sp), pancreas (Pc), and kidney (Kd). The 500-bpThe prevalence of each of the six TTV genotypes in the
serum and each tissue specimen of Subject A is shownin Table 4. Among the total of 300 clones obtained,
genotype 18 was the most common, comprising 47% of
them, and this genotype was distributed widely in the
serum and in eight of the nine tissue specimens at a
frequency ranging from 7% (muscle) to 100% (lymph
node). Genotypes 24 and 26 comprised 28 and 21%,
respectively, of the total number of clones. However,
genotypes 24 and 26 were each not detected in three of
the nine tissues, and both genotypes were not detected
in the lymph node, where genotype 18 prevailed. Geno-
type 25 was not detected in the circulation, despite being
present in the spleen and kidney. Genotype 19 was
observed only in the serum and pancreas. Each of the six
genotypes was distributed in one to eight tissues. In
other words, each tissue was infected with TTV of one to
four genotypes among the six examined, indicating the
heterogeneous distribution of TTV genotypes in multiple
tissues.
Detection of TTV mRNA in tissues
Taking advantage of the presence of a splicing (ap-
proximately 100 nt) in all three TTV mRNAs at their 59
ends (Kamahora et al., 2000; Okamoto et al., 2000b),
nested RT-PCR was performed to specifically detect
spliced TTV mRNA in the various tissues obtained from
Subject A. Antisense primers specific for TTV of geno-
type 18 or 24 (NG512 or NG510 in the first round and
NG525 or NG523 in the second round) were used for the
nested PCR, because these two genotypes prevailed in
all tissue specimens at prevalence of .50% in total
(Table 4). TTV mRNA of genotype 18 was detected in all
tissues except for the pancreas, in accordance with the
serum and various tissues obtained from three subjects (A, B, and C).
e, MvaI, and electrophoresed on a 1.5% agarose gel. Lane S represents
e marrow (Bm), lymph node (Ln), muscle (Ms), thyroid gland (Th), lung
adder (TaKaRa Shuzo) on the left served as a molecular marker.m the
ucleaspresence of TTV DNA of genotype 18 in these tissues
(Fig. 3A). Furthermore, TTV mRNA of genotype 24 was
362 OKAMOTO ET AL.detected in the bone marrow, muscle, lung, liver, spleen,
and pancreas, where TTV DNA of the corresponding
genotype was present. Sequence analysis of the PCR-
amplified product could confirm the presence of mRNAs
specific for TTV of genotype 18 or 24, in complete agree-
ment with the existence of either or both of the two
distinct TTVs in the tissue specimens (Fig. 3B). The
FIG. 2. Phylogenetic tree constructed by the neighbor-joining method
of the nucleotide sequence of ORF1 in 34 TTV isolates. The nucleotide
sequence of ORF1 of 28 TTV isolates (genotypes 1–3 and 10–23) of
which the entire sequence of ORF1 is known (Hijikata et al., 1999;
Muljono et al., 2001; Mushahwar et al., 1999; Okamoto et al., 1999b,
2000b; Takahashi et al., 2000a; Tanaka et al., 2001; Ukita et al., 2000),
and the six isolates obtained in the present study (SAa-01, SAa-10,
SAa-38, SAa-39, SAf-09, and SAj-30, indicated in bold type) are com-
pared. Bootstrap values were .90% for junctures, which were consid-
ered to support the observed grouping. The accession number for each
isolate is TA278, AB017610; TTVCHN1, AF079173; GH1, AF122913; JA20,
AF122914; JA1, AF122916; US32, AF122921; JA10, AF122919; T3PB,
AF247138; PMV, AF261761; Kt-08F, AB054647; Kt-10F, AB054648; SAN-
BAN, AB025946; TJN02, AB028669; SENV-E, AX025761; SAa-10,
AB060594; SAj-30, AB060595; TYM9, AB050448; SAa-39, AB060592;
SAf-09, AB060596; SAa-01, AB060597; SENV-B, AX025677; TUS01,
AB017613; TUPB, AF247137; SENV-C, AX025718; SENV-H, AX025838;
TJN01, AB028668; SENV-D, AX025730; SENV-F, AX025822; SAa-38,
AB060593; SENV-G, AX025830; TTVyon-KC009, AB038621; TTVyon-
KC197, AB038624; TTVyon-LC011, AB038622; and TTVyon-KC186,
AB038623.splicing site of the TTV mRNAs for the TTV isolate of
genotype 18 or 24 was concordant with the presumptionbased on the GT-AG splicing rule (Breathnach et al.,
1978; Mount, 1982).
DISCUSSION
The present study showed that TTV is distributed not
only in the liver and bone marrow in accordance with
previous reports (Kikuchi et al., 2000; Lopez-Alcorocho et
al., 2000; Okamoto et al., 1998a, 2000d,e), but also in
seven other tissues that were examined, including the
lung, spleen, pancreas, kidney, lymph node, skeletal
muscle, and thyroid gland, and that the TTV viral load
differs in different tissues and is relatively higher in the
bone marrow, lung, spleen, and liver, although it varied
by infected individual. In addition, double-stranded TTV
DNA as replicative intermediate forms and TTV mRNA
were detected in all tissues examined, suggesting that
TTV replicates in multiple tissues in the infected hosts,
which could contribute to the viremia level and popula-
tion of TTV in the circulation. TTV DNA is detected in a
variety of clinical specimens obtained from infected in-
dividuals, such as the serum/plasma, bile, feces, saliva,
throat swabs, breast milk, and semen (Deng et al., 2000;
Inami et al., 2000; Ishikawa et al., 1999; Matsubara et al.,
2000; Okamoto et al., 1998b; Ross et al., 1999; Ukita et al.,
1999). Therefore, it seems likely that TTV can also repli-
cate in other tissues not examined in the present study.
The salivary glands, oropharyngeal tissues, mammary
gland, and gonad have to be searched for the presence
of double-stranded TTV DNA and TTV mRNA in future
studies. In addition, extended studies are required to
elucidate the exact location of TTV by in situ hybridiza-
tion as was performed for the study of TTV in the liver
(Cheng et al., 2000; Jiang et al., 2000; Rodriguez-Inigo et
al., 2000) and detection of the virus-encoded proteins in
various tissues testing positive for TTV DNA must be
performed.
It was recently found that three distinct mRNAs of
2.9–3.0, 1.2, and 1.0 kb with common 59 and 39 termini are
transcribed from the TTV genome and that these three
mRNAs have in common a short splicing of approxi-
mately 100 nt at their 59 termini (Kamahora et al., 2000;
Okamoto et al., 2000b). Taking advantage of the pres-
ence of the short splicing in all TTV mRNAs, a method to
specifically detect TTV mRNA was developed in the
present study. The target region which includes the splic-
ing site was amplified by RT-PCR: the length of the
amplified product, which is 100 nt shorter than that of the
TTV genome sequence, is indicative of the presence of
TTV mRNA. In this regard, the method to detect TTV
mRNA as an indirect marker of viral replication would be
useful for further investigation of the tissue tropism of
TTV.
Several reports have indicated the heterogeneity of the
TTV population in the circulation of infected subjects
(Ball et al., 1999; Forns et al., 1999; Okamoto et al., 1999c;
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363TISSUE DISTRIBUTION OF TT VIRUSTakayama et al., 1999). The results obtained in the
present study show that TTV genotypes exhibit marked
heterogeneity with respect to their distribution not only in
the serum but also in various tissues. TTV genotypes not
present in the serum were detected in various tissues;
these included genotypes 4 and 25 in Subject A; geno-
type 3 in Subject B; and genotype 2 in Subject C (Tables
3 and 4). These results would indicate persistence of
TTV infection in tissues after the host has cleared it from
the circulation and suggest that these tissues may act as
T
Distribution of TTV of Six Genotypes Based
from the Serum and Each
Source of TTV clone
(name of clone)b
Number
18 19
erum (SAa) 8 (27%) 1 (3%)
Bone marrow (SAb) 7 (23%) 0
ymph node (SAc) 30 (100%) 0
uscle (SAd) 2 (7%) 0
hyroid gland (SAe) 20 (67%) 0
ung (SAf) 25 (83%) 0
iver (SAg) 19 (63%) 0
Spleen (SAh) 15 (50%) 0
Pancreas (SAi) 0 1 (3%)
Kidney (SAj) 16 (53%) 0
Total 142 (47%) 2 (1%)
a The number of clones of the dominant genotype(s) in each specim
b TTV DNA clones obtained were named after Subject A (SA in upp
specimens, and individual clone numbers; some representative clones
FIG. 3. Detection of TTV mRNA in the serum and various tissues fr
amplified by RT-PCR. The migration positions of the amplified TTV cDNA
for bone marrow (Bm), lymph node (Ln), muscle (Ms), thyroid gland (Th),
was amplified from serum (S). (B) Nucleotide sequences of TTV cDNA [
DNA amplifiable by the same primer pair (NG470–NG525 or NG470–NG
top row, and a slash indicates a deletion. The nucleotide sequences were iden
tissues, and among those of genotype 24 obtained from six tissues that werea reservoir. On the other hand, genotypes detected in the
serum were not necessarily found in all tissues exam-
ined. With regard to genotype 19 in Subject A, it was
detected only in the pancreas other than the serum.
Genotypes 18, 24, 26, and 27 were not detected in one to
six tissues among the nine examined in Subject A. Fur-
thermore, TTV of genotype 1 was detected in the liver,
pancreas, and kidney of all three patients, while TTV of
genotype 3 or 4 was detected in other tissues (bone
marrow, thyroid gland, lung, or spleen) in Subjects A and
Analysis of 30 TTV DNA Clones Isolated
sy Tissue from Subject A
es (percentage) of each TTV genotypea
24 25 26 27
3 (43%) 0 5 (17%) 3 (10%)
1 (37%) 0 11 (37%) 1 (3%)
0 0 0 0
7 (57%) 0 10 (33%) 1 (3%)
0 0 10 (33%) 0
1 (3%) 0 4 (13%) 0
1 (3%) 0 10 (33%) 0
4 (47%) 1 (3%) 0 0
8 (93%) 0 0 1 (3%)
0 1 (3%) 13 (43%) 0
5 (28%) 2 (1%) 63 (21%) 6 (2%)
in total is indicated in bold type.
letters), alphabetical order (a to j in lowercase letters) for each of 10
own in Fig. 2.
ject A. (A) Agarose gel electrophoresis of TTV cDNAs that had been
p for genotype 18 (top) and 75 bp for genotype 24 (bottom)] are shown
g), liver (Lv), spleen (Sp), pancreas (Pc), and kidney (Kd). No PCR signal
genotype 18) or 75 bp (genotype 24)], in comparison with those of TTV
A dash indicates an identical nucleotide to that in the sequence in theABLE 4
on the
Autop
of clon
1
1
1
1
2
8
en orom Sub
s [63 b
lung (L
63 bp (
523).
tical among the TTV cDNA clones of genotype 18 obtained from eight
positive for TTV mRNA of the respective genotype as shown in (A).
364 OKAMOTO ET AL.B (Table 3). TTV of genotype 25 was only seen in the
spleen and kidney of Subject A. Such a tissue-dependent
distribution has been reported for different subtypes or
genotypes of human immunodeficiency virus type 1 and
Epstein–Barr virus (Chen et al., 1996; Peeters et al., 1999;
Triantos et al., 1998; Tscherning et al., 1998). Although the
underlying basis for our finding that multiple and distinct
viral genotypes are present in various tissues of the
same individual remains unknown, it is tempting to spec-
ulate that some genotypes might be better adapted for
growth within some compartments of an infected host.
Identification of the host and viral factors that might
govern the heterogeneous distribution and persistent
infection of TTV is an important area for future study.
The possible implications of TTV genome diversity are
difficult to assess due to the marked complexity and
frequent mixed infection of multiple TTV genotypes dis-
tributed in various tissues, as demonstrated in the
present study. Furthermore, the range of TTV genome
variability is not yet fully understood. In fact, four geno-
types were newly identified in a single patient in the
present study, and it is likely that the number of TTV
genotypes will continue to increase in future studies.
However, the finding that certain human papillomavirus
types are implicated in cervical neoplasms while others
are associated with benign tumors demonstrates the
broad spectrum of possible outcomes of persistent in-
fection caused by a DNA virus with multiple genotypes
(Shah and Howley, 1996). Therefore, the possibility that
TTV genome variability influences the disease pathogen-
esis of TTV and host immune responses warrants further
study.
The spectrum of human disease associated with TTV
infection remains to be established. TTV genomes were
detected in patients with cryptogenic posttransfusion
hepatitis, and the emergence of viremia coincided with
the increase in serum alanine aminotransferase (ALT)
level (Nishizawa et al., 1997), implying that TTV may be
the cause of some cryptogenic liver diseases. Based on
a transmission study of TTV to a naive chimpanzee that
contracted a transient TTV infection and developed ele-
vation of ALT level and histological changes in the liver in
parallel with the reduction in TTV viremia level (Tawara et
al., 2000), it has been suggested that TTV has hepatitis-
inducing capacity, at least in some clinical and epidemi-
ologic settings. Besides the liver, replication of TTV was
observed at higher levels in the bone marrow, lung, and
spleen in the present study. The possible association of
aplastic anemia, thrombocytopenia, or idiopathic pulmo-
nary fibrosis with TTV infection has been suggested
(Bando et al., 2001; Kikuchi et al., 2000; Tokita et al.,
2001). Therefore, the pathogenic role of TTV infection not
only in the liver, but also in other organs/tissues, de-
serves further analysis.In conclusion, our data demonstrate the frequent co-
existence of multiple TTV genotypes in various tissues of
T
(infected humans and suggest that TTV replicates in
multiple tissues, although the replication level differs
according to TTV genotype, tissue, and the infected in-
dividual. In the majority of cases, TTV may subclinically
infect various tissues of the body and establish persis-
tent viremia. However, there is a possibility that TTV
exhibits pathogenicity through several avenues, such as
the requirement for activation by superinfection with an-
other virus, or that certain TTV genotypes or strains may
be more pathogenic than others (Okamura et al., 2000;
Shibata et al., 2000; Sugiyama et al., 2000; Tanaka et al.,
2000), possibly in a tissue-dependent manner. In this
regard, ongoing investigations are needed to fully under-
stand the exact properties and pathogenic role of this
newly recognized human virus with a circular, single-
stranded DNA genome.
MATERIALS AND METHODS
Serum and tissue specimens
Nine tissue specimens (bone marrow, lymph node of
mesentery, muscle of quadriceps, thyroid gland, lung,
liver, spleen, pancreas, and kidney) were obtained dur-
ing routine autopsies conducted within 48 h of death
from each of three male, TTV-infected patients (Subjects
A, B, and C; 54–65 years of age) who had suffered from
alcoholic liver cirrhosis and died of hepatic insufficiency.
A serum sample was separated from the heart blood at
autopsy. The serum and tissue specimens were stored at
280°C until testing. All three patients were tested neg-
ative for hepatitis B surface antigen (MyCell, Institute of
Immunology Co., Ltd., Tokyo, Japan), antibodies to hep-
atitis C virus (ELISA-II, Ortho Diagnostic Systems, Tokyo,
Japan), and antibodies to human immunodeficiency virus
type 1 (SERODIA-HIV, Fujirebio, Tokyo, Japan).
Extraction of nucleic acids from serum and tissue
specimens
Nucleic acids were extracted from 100 ml of serum
using the High Pure Viral Nucleic Acid Kit (Roche Diag-
nostics GmbH, Mannheim, Germany) and eluted in 50 ml
nuclease-free distilled water. A piece of tissue specimen
(200 mg) was homogenized and incubated in the pres-
ence of 0.5 mg/ml proteinase K and 0.5% (wt/vol) sodium
dodecyl sulfate at 37°C for 14 h as described previously
(Okamoto et al., 2000e). Then, the nucleic acids were
extracted from the tissue specimen with phenol-chloro-
form and precipitated with ethanol. DNA species of chro-
mosomal origin, which emerged as a cloudy precipitate
immediately after the addition of ethanol, was removed.
The remaining nucleic acids were collected by centrifu-
gation (20,130 g, 4°C, 15 min) and dissolved in 200 ml ofris–HCl buffer (10 mM, pH 8.0) containing 1 mM EDTA
TE buffer).
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365TISSUE DISTRIBUTION OF TT VIRUSQuantitation of TTV DNA
TTV DNA was quantitated by real-time detection PCR
using 2 ml of the nucleic acid solution as a template,
rimers NG473 and NG352 derived from a well-con-
erved untranslated region of the TTV genome (Table 5),
dual fluorophore-labeled probe [NG369-P: 59-(Fam)-
GT CAA GGG GCA ATT CGG GCT CGG GA-(Tamra)-39],
nd the LightCycler-FastStart DNA Master Hybridization
robes Kit (Roche Diagnostics GmbH). PCR amplification
as started with an initial denaturation at 95°C for 10
in, followed by 50 cycles of denaturation at 95°C for
0 s and annealing–extension at 62°C for 30 s. All reac-
ions were performed in a LightCycler System (Roche
iagnostics GmbH). The real-time UTR PCR can detect
ssentially all TTV genotypes. The quantification limit of
he system was three to five copies per test capillary (20
ml of reaction mixture).
Quantitative detection of the four common TTV
genotypes (1, 2, 3, and 4)
Each serum and tissue specimen was tested for the
presence of the four common TTV genotypes, 1, 2, 3, and
4. PCR was performed in the presence of Perkin–Elmer
AmpliTaq Gold (Roche Molecular Systems, Inc., Branch-
burg, NJ) for 35 cycles with an initial denaturation at 95°C
for 9 min (95°C for 30 s; 58°C for 30 s; 72°C for 40 s, with
T
Positions and Nucleotide Seq
Primer Polarity Nucleotide positio
NG137 Antisense 3362–3385
NG138 Antisense 3337–3360
NG173 Sense N22b (genotype 2)
NG223 Sense N22 (genotype 1)
NG224 Antisense N22 (genotype 1)
NG225 Sense N22 (genotype 1)
NG226 Antisense N22 (genotype 1)
NG352 Antisense 229–252
NG415 Sense N22 (genotype 3)
NG416 Antisense N22 (genotype 3)
NG417 Antisense N22 (genotype 4)
NG418 Sense N22 (genotype 4)
NG470 Sense 163–182
NG473 Sense 174–197
NG484 Sense 113–133
NG510 Antisense UTRc (genotype 24)
NG512 Antisense UTR (genotype 18)
NG522 Antisense UTR (genotypes 18 a
NG523 Antisense UTR (genotype 24)
NG525 Antisense UTR (genotype 18)
a Nucleotide positions are in accordance with the 3853-nucleotide s
b The N22 region is located in the central region of open reading fra
c UTR (untranslated region) corresponds to nt 3075–3853 and nt 1–3an additional 7 min in the last cycle) in the first round.
The second round of PCR was performed using 2 ml ofthe product of the first-round PCR for 25 cycles under the
same conditions. The primer pairs specific for genotypes
1–4 that were used were NG223–NG224, NG198–NG063,
NG415–NG416, and NG177–NG417, respectively, in the
first round, and NG225–NG226, NG173–NG174, NG193–
NG180, and NG418–NG178, respectively, in the second
round (Table 5): seven of these primers (italicized) have
previously been described (Okamoto et al., 2000a). The
mplification products were electrophoresed on a 3–4%
wt/vol) NuSieve 3:1 agarose gel (FMC BioProducts,
ockland, ME) to detect bands compatible with geno-
ypes 1–4, which were sized at 137, 64, 74, and 123 bp,
espectively. Semiquantitation of TTV of distinct geno-
ypes was performed as follows. Nucleic acids extracted
rom each of the serum and tissue specimens were
iluted serially 10-fold in distilled water containing 20 mg
f glycogen per milliliter (Roche Diagnostics GmbH) and
ested for genotype 1, 2, 3, or 4 by nested PCR as
escribed above. The titer of TTV DNA of a certain
enotype was expressed as the highest dilution (10n)
testing positive.
Amplification and molecular cloning of 3.3-kb-long
TTV DNA
Nucleic acids extracted from the serum and tissue
specimens from each of the three patients were sub-
jected to long-distance nested PCR for amplification of a
s of Oligonucleotide Primers
Nucleotide sequence
59-GGC AAG AAG ATA AAG GCC TTA TGG-39
59-GAA GTC TGG CCC CAC TCA CTT TCG-39
59-GAT ACA CAG AAT ACT GCA GC-39
59-CAG ACC TAC CWC TRT GGG CAG C-39
59-CAA AGC CTT TWG TGG GGT CTG-39
59-CTR TGG GCA GCA GCA TAT GG-39
59-TTT GTG GGG TCT GTG TGT AC-39
59-GAG CCT TGC CCA TRG CCC GGC CAG-39
59-CCC GCA GCA AAT GCC TTA TAG-39
59-CCC CTG CCA AAG TTA AAG CTG-39
59-TTC GCT ATA GGG GAC GAA GC-39
59-CAG ACT ACT GCA GAA AGG TC-39
59-CGT CCC GAG GGC GGG TGC CG-39
59-CGG GTG CCG DAG GTG AGT TTA CAC-39
59-GAG TTT TCC ACG CCC GTC CGC-39
59-TTG AGG GGA CAT GTC TCA TCG-39
59-GTG GGT GCT GCT TAG TAA CGG-39
59-ACA GCC ACA AAA RGY AGY GTG-39
59-TGG AGT CTG CAC AGC CAG CAG-39
59-TGG AGG GTG CAC AGG TAG CAG-39
e of the prototype TTV isolate (TA278) (Okamoto et al., 1999b).
and corresponds to nt 1847–2346 of the TA278 isolate.
he TA278 isolate.ABLE 5
uence
nsa
nd 24)
equenc3.3-kb-long TTV DNA (3.3-kb PCR) by the previously de-
scribed method (Okamoto et al., 1999c), with different
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366 OKAMOTO ET AL.sets of primers. In brief, primers NG133 (sense) and
NG137 (antisense) were used for the first-round PCR and
primers NG249 (sense) and NG138 (antisense) for the
second-round PCR (Table 5): the italicized primer has
previously been described (Okamoto et al., 2000c). The
amplification products were subjected to RFLP analysis
as described below. They were also ligated into the
pT7BlueT vector (Novagen Inc., Madison, WI), and 30
clones were obtained from each of the 10 specimens
from Subject A.
RFLP analysis
The PCR-amplified products or molecular clones were
digested with restriction endonuclease DraI, Sau3AI, or
MvaI (TaKaRa Shuzo, Shiga, Japan). They were then elec-
trophoresed on a 1.5% SeaKem GTG agarose gel (FMC
BioProducts), stained with ethidium bromide, and photo-
graphed under ultraviolet light.
Detection of double-stranded TTV DNA in tissues
Double-stranded TTV DNAs representing replicative
intermediates were detected by the previously described
method (Okamoto et al., 2000d), with slight modifications.
Briefly, after electrophoresis of the extracted nucleic ac-
ids from tissue specimens with TTV viral load of 106
copies/g or greater, the area of the agarose gel corre-
sponding to 2.7–6.8 kb was cut into 12 gel slices, and the
DNA was recovered from each gel slice. The stranded-
ness of the TTV DNAs in the gel slices was evaluated by
treatment with S1 nuclease (TaKaRa Shuzo), followed by
PCR amplification using primers NG133 (sense) and
NG352 (antisense), as described previously (Okamoto et
l., 2000c). In addition, extracted nucleic acids from each
f all serum and tissue specimens were subjected to the
reatment with S1 nuclease and then quantitated by the
bovementioned real-time UTR PCR. To confirm the dou-
le-strandedness of the S1 nuclease-treated nucleic ac-
ds, they were further treated with restriction endonucle-
se AccI, AccII, ApaI, HincII, StuI, or HaeIII (TaKaRa
Shuzo), followed by the conventional nested UTR PCR
(Okamoto et al., 2000c) or 3.3-kb PCR as described
bove: six distinct TTV DNA clones (SAa-01, SAa-10,
Aa-38, SAa-39, SAf-09, and SAj-30) isolated from Sub-
ect A had in common one or more recognition se-
uences for each of these restriction enzymes at various
ites in the 3.3-kb sequence.
NA extraction and reverse transcription (RT)-PCR
Total RNA was extracted from 100 ml of serum or 200
mg of each tissue specimen with guanidium thiocyanate
and phenol-chloroform using ISOGEN-LS or ISOGEN
(Nippon Gene, Tokyo, Japan), respectively, and then sub-
jected to digestion with RNase-free DNase I (TaKaRa
Shuzo) to remove the residual DNA molecules.
The RNA preparation thus obtained was reverse tran-scribed with SuperScript II RNase H2 reverse transcrip-
ase (GIBCO-BRL, Grand Island, NY) and a primer
NG522) specific for TTV isolates obtained from Subject
in the present study and then subjected to nested PCR
n the presence of Perkin–Elmer AmpliTaq DNA polymer-
se (Roche Molecular Systems). Briefly, a region includ-
ng the area which is presumed to be spliced out in all
hree TTV mRNAs at their 59 termini was amplified using
he sense primer NG484 and the antisense primer
G510 or NG512 for the first round and the sense primer
G470 and the antisense primer NG523 or NG525 for the
econd round. The PCR amplification was carried out for
5 cycles in the first round (94°C for 30 s, with an
dditional 2 min in the first cycle; 58°C for 30 s; 72°C for
0 s, with an additional 7 min in the last cycle) and for 25
ycles in the second round under the same conditions
xcept for extension for 45 s. The amplified PCR prod-
cts were molecularly cloned and sequenced.
etermination and analysis of nucleotide sequence
The obtained TTV DNA or cDNA clones were se-
uenced on both strands by the previously described
ethod (Okamoto et al., 1999b) using the BigDye Termi-
ator Cycle Sequencing Ready Reaction Kit (Applied Bio-
ystems, Foster City, CA). Sequence analysis was per-
ormed with Genetyx-Mac version 10.1.4 (Software Devel-
pment Co., Tokyo, Japan) and ODEN version 1.1.1 (Ina,
994) from the DNA Data Bank of Japan (National Insti-
ute of Genetics, Mishima, Japan). Sequence alignments
ere generated by the CLUSTAL W program version 1.8
Thompson et al., 1994). Phylogenetic relatedness
mong TTV sequences was estimated by the neighbor-
oining method (Saitou and Nei, 1987). The reliability of
he phylogenetic results was assessed using 1000 boot-
trap replicates (Felsenstein, 1985).
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